04/03/2024
6:30 AM | Finch Therapeutics Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:15 PM | Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:33 PM | Finch Therapeutics Group (Subject)
SMISEK JEFFERY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
4:20 PM | Finch Therapeutics Group (Subject)
Ugwumba Chidozie (Filed by)
| Form SC 13G | |
11/27/2023
3:54 PM | Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:37 PM | Finch Therapeutics Group (Subject)
SMISEK JEFFERY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
3:30 PM | Finch Therapeutics Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
5:30 AM | Finch Therapeutics Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
5:31 AM | Finch Therapeutics Group (Filer)
| Form 10-Q/A | |
08/10/2023
5:31 AM | Finch Therapeutics Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/28/2023
3:31 PM | Finch Therapeutics Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:30 PM | Blischak Matthew P. (Reporting)
Finch Therapeutics Group (Issuer)
| Form 4/A | |
06/23/2023
6:30 AM | Finch Therapeutics Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
2:05 PM | Finch Therapeutics Group (Issuer)
Shumway Chris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
3:17 PM | Blischak Matthew P. (Reporting)
Finch Therapeutics Group (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/10/2023
6:12 AM | Finch Therapeutics Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:14 AM | Finch Therapeutics Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2023
3:01 PM | Finch Therapeutics Group (Filer)
| Form DEF 14A | |
04/26/2023
3:02 PM | Finch Therapeutics Group (Filer)
| Form DEFA14A | |
